Peirong Hu

987 total citations
18 papers, 423 citations indexed

About

Peirong Hu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Peirong Hu has authored 18 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Genetics. Recurrent topics in Peirong Hu's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and CRISPR and Genetic Engineering (4 papers). Peirong Hu is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and CRISPR and Genetic Engineering (4 papers). Peirong Hu collaborates with scholars based in United States, Japan and Germany. Peirong Hu's co-authors include Joseph L. Napoli, Dina Schneider, Min Zhang, Ying Xiong, Darong Wu, Boro Dropulić, Maureen A. Kane, Charles R. Krois, Zhongyu Zhu and Leah Alabanza and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Peirong Hu

17 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peirong Hu United States 12 222 221 97 94 67 18 423
Anne M. Miermont United States 7 111 0.5× 239 1.1× 86 0.9× 97 1.0× 57 0.9× 11 346
Xinyi Xiao China 6 126 0.6× 241 1.1× 60 0.6× 85 0.9× 89 1.3× 14 383
Xuelian Hu China 12 182 0.8× 144 0.7× 63 0.6× 196 2.1× 25 0.4× 16 423
Markus Thiel Germany 8 142 0.6× 77 0.3× 25 0.3× 125 1.3× 15 0.2× 10 339
Mala K. Talekar United States 11 197 0.9× 203 0.9× 41 0.4× 63 0.7× 21 0.3× 17 372
Sara Caratelli Italy 11 154 0.7× 281 1.3× 36 0.4× 215 2.3× 76 1.1× 15 495
Anže Smole Slovenia 6 198 0.9× 115 0.5× 27 0.3× 86 0.9× 57 0.9× 8 322
Ben Buelow United States 13 203 0.9× 372 1.7× 18 0.2× 131 1.4× 40 0.6× 33 611
Angelos Papaspyropoulos United Kingdom 14 302 1.4× 103 0.5× 23 0.2× 43 0.5× 42 0.6× 20 492
Bowen Xing China 11 211 1.0× 151 0.7× 29 0.3× 55 0.6× 36 0.5× 22 458

Countries citing papers authored by Peirong Hu

Since Specialization
Citations

This map shows the geographic impact of Peirong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peirong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peirong Hu more than expected).

Fields of papers citing papers by Peirong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peirong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peirong Hu. The network helps show where Peirong Hu may publish in the future.

Co-authorship network of co-authors of Peirong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peirong Hu. A scholar is included among the top collaborators of Peirong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peirong Hu. Peirong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Tran, Tri, Bal Krishna Chand Thakuri, Saule Nurmukhambetova, et al.. (2024). Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1. Journal for ImmunoTherapy of Cancer. 12(4). e008261–e008261. 15 indexed citations
3.
Alabanza, Leah, Ying Xiong, Bang K. Vu, et al.. (2022). Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Frontiers in Immunology. 13. 832645–832645. 41 indexed citations
4.
Webster, Brian, Ying Xiong, Peirong Hu, et al.. (2021). Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models. Molecular Therapy. 29(9). 2691–2706. 26 indexed citations
5.
Schneider, Dina, Ying Xiong, Darong Wu, et al.. (2021). Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models. Science Translational Medicine. 13(586). 100 indexed citations
6.
Hu, Peirong, Ying Xiong, Darong Wu, et al.. (2020). Fully Human Tandem CD22-CD19 CAR-T Cells with Superior Sensitivity to Low Antigen Density Derived by Optimization of Co-Stimulation and CAR Architecture. Blood. 136(Supplement 1). 12–13. 4 indexed citations
7.
Bagashev, Asen, et al.. (2020). Abstract 3234: Multi-antigen targeting of CD19, CD22 and TSLPR to prevent Ph-like ALL resistance. Cancer Research. 80(16_Supplement). 3234–3234. 2 indexed citations
8.
Schneider, Dina, Ying Xiong, Peirong Hu, et al.. (2018). A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia. Frontiers in Oncology. 8. 539–539. 32 indexed citations
9.
Hu, Peirong, et al.. (2018). Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Therapy. 25(7). 454–472. 12 indexed citations
10.
Suwanmanee, Thipparat, Martin T. Ferris, Peirong Hu, et al.. (2017). Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery. Molecular Therapy — Methods & Clinical Development. 5. 83–92. 13 indexed citations
11.
Hu, Peirong, Yedda Li, Nana Nikolaishvili‐Feinberg, et al.. (2016). Hematopoietic Stem cell transplantation and lentiviral vector‐based gene therapy for Krabbe's disease: Present convictions and future prospects. Journal of Neuroscience Research. 94(11). 1152–1168. 16 indexed citations
12.
Hu, Peirong, Yedda Li, Mark S. Sands, Thomas J. McCown, & Tal Kafri. (2015). Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors. Molecular Therapy — Methods & Clinical Development. 2. 15025–15025. 15 indexed citations
13.
Singh, Pratibha, Jonathan Hoggatt, Peirong Hu, & Louis M. Pelus. (2012). Sinusoidal Endothelial CD26 Cleavage of Neuropeptide Y Regulates Transendothelial Migration and Mobilization of Hematopoietic Stem and Progenitor Cells in Response to G-CSF.. Blood. 120(21). 2347–2347. 1 indexed citations
14.
Chitteti, Brahmananda R., Michihiro Kobayashi, Ying‐Hua Cheng, et al.. (2012). CD166 (ALCAM): A Functional Marker of Primitive Murine and Human Hematopoietic Stem Cells and Cellular Elements of Their Niche. Blood. 120(21). 640–640. 1 indexed citations
15.
Singh, Pratibha, Jonathan Hoggatt, Peirong Hu, et al.. (2011). Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood. 119(7). 1671–1682. 37 indexed citations
16.
Zhang, Min, Peirong Hu, Charles R. Krois, Maureen A. Kane, & Joseph L. Napoli. (2007). Altered vitamin A homeostasis and increased size and adiposity in the rdhl‐null mouse. The FASEB Journal. 21(11). 2886–2896. 79 indexed citations
17.
Hu, Peirong, Min Zhang, & Joseph L. Napoli. (2006). Ontogeny of rdh9 (Crad3) expression: Ablation causes changes in retinoid and steroid metabolizing enzymes, but RXR and androgen signaling seem normal. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(4). 694–705. 9 indexed citations
18.
Zhang, Min, Peirong Hu, & Joseph L. Napoli. (2004). Elements in the N-terminal Signaling Sequence That Determine Cytosolic Topology of Short-chain Dehydrogenases/Reductases. Journal of Biological Chemistry. 279(49). 51482–51489. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Miermont Breakdown of academic impact, for papers by Xinyi Xiao Breakdown of academic impact, for papers by Xuelian Hu Breakdown of academic impact, for papers by Markus Thiel Breakdown of academic impact, for papers by Mala K. Talekar Breakdown of academic impact, for papers by Sara Caratelli Breakdown of academic impact, for papers by Anže Smole Breakdown of academic impact, for papers by Ben Buelow Breakdown of academic impact, for papers by Angelos Papaspyropoulos Breakdown of academic impact, for papers by Bowen Xing
Rankless by CCL
2026